We are live on ! Find out more
VP

venBio Partners Portfolio holdings

AUM $519M Turnover 37.5%
1-Year Est. Return 339.42%
This Fund
S&P 500
This Quarter Est. Return
-1.57%
1 Year Est. Return
+339.42%
3 Year Est. Return
+563.8%
5 Year Est. Return
+1,003.88%
10 Year Est. Return
–
AUM
$211M
AUM Growth
-$14.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
0.8 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.8 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AKRO icon
1
DELISTED
Akero Therapeutics
AKRO
$90M 42.68%
3,954,858
– –
2019 Q2
1 quarter
TPTX
2
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$50.4M 23.91%
1,340,265
– –
2019 Q2
1 quarter
DTIL icon
3
Precision BioSciences
DTIL
$170M
$35.8M 16.98%
142,171
– –
2019 Q1
2 quarters
APLS icon
4
DELISTED
Apellis Pharmaceuticals
APLS
$24.1M 11.43%
1,000,000
– –
2018 Q4
3 quarters
YARW
5
Yarrow Bioscience
YARW
$169M
$6.55M 3.11%
406
– –
2018 Q1
6 quarters
VRNA
6
DELISTED
Verona Pharma
VRNA
$4M 1.9%
875,000
– –
2017 Q4
7 quarters

Similar funds

CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
CFG
Compton Financial Group Towson, Maryland $519M AUM 14.76% 1-Year Est. Return
MWM
Mindset Wealth Management Indianapolis, Indiana $519M AUM 46.03% 1-Year Est. Return
SWM
Scissortail Wealth Management Tulsa, Oklahoma $520M AUM 21.73% 1-Year Est. Return
WS
Wendel SE Paris $519M AUM 48.2% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
MWC
MBM Wealth Consultants Chesterfield, Missouri $519M AUM 16.88% 1-Year Est. Return
PDIP
Palo Duro Investment Partners Chicago, Illinois $518M AUM 22.62% 1-Year Est. Return

venBio Partners's Q3 2019 Portfolio in Review

As of Q3 2019, venBio Partners held 6 positions worth $211M, down 6.5% from $225M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 0%. venBio Partners opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • venBio Partners's ten largest holdings make up 100% of its $211M portfolio in Q3 2019.
  • venBio Partners opened 0 new positions and closed 0 in Q3 2019.
  • venBio Partners's portfolio value fell 6.5% quarter-over-quarter to $211M.

Based on venBio Partners's 13F filing for Q3 2019, filed 14 Nov 2019.